Imexpharm Equity Turnover

Equity Turnover of Imexpharm is 1.06 in 2026.

Equity Turnover of Imexpharm changed from 1.01 to 1.06, representing a 4.78% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Equity Turnover Imexpharm since 2006 – with annual values, charts, and detailed analysis.

Equity turnover measures how efficiently a company uses shareholders' equity to generate revenue. It is a component of the DuPont analysis framework.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Turnover's Imexpharm with sector peers and the industry average to assess whether it is attractive.

To evaluate Equity Turnover's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Equity Turnover.